PROCEPT BioRobotics Corp.PROCEPT BioRobotics Corp.PROCEPT BioRobotics Corp.

PROCEPT BioRobotics Corp.

No trades
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪26.77 B‬MXN
−28.19MXN
‪−1.91 B‬MXN
‪4.68 B‬MXN
‪53.81 M‬
Beta (1Y)
1.09
Employees (FY)
756
Change (1Y)
+130 +20.77%
Revenue / Employee (1Y)
‪6.19 M‬MXN
Net income / Employee (1Y)
‪−2.52 M‬MXN

About PROCEPT BioRobotics Corporation


CEO
Larry L. Wood
Headquarters
San Jose
Founded
2007
IPO date
Sep 15, 2021
Identifiers
3
ISIN US74276L1052
PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in San Jose, CA.

Check out other big names from the same industry as PRCT.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
IWM
iShares Russell 2000 ETF
Weight
0.05%
Market value
‪36.57 M‬
USD
VBK
Vanguard Small-Cap Growth ETF
Weight
0.05%
Market value
‪19.36 M‬
USD
IWO
iShares Russell 2000 Growth Fund
Weight
0.09%
Market value
‪12.43 M‬
USD
SCHA
Schwab U.S. Small-Cap ETF
Weight
0.04%
Market value
‪7.51 M‬
USD
VTWO
Vanguard Russell 2000 ETF
Weight
0.05%
Market value
‪7.35 M‬
USD
IHI
iShares U.S. Medical Devices ETF
Weight
0.20%
Market value
‪7.06 M‬
USD
VHT
Vanguard Health Care ETF
Weight
0.02%
Market value
‪4.85 M‬
USD
KOMP
State Street SPDR S&P Kensho New Economies Composite ETF
Weight
0.18%
Market value
‪4.39 M‬
USD
R2US
SPDR Russell 2000 U.S. Small Cap UCITS ETF
Weight
0.05%
Market value
‪2.42 M‬
USD
VTWG
Vanguard Russell 2000 Growth ETF
Weight
0.10%
Market value
‪1.42 M‬
USD
RBTZ
BetaShares Global Robotics & Artificial Intelligence ETF
Weight
0.62%
Market value
‪1.31 M‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of PRCT is 543.54 MXN — it has increased by 1.41% in the past 24 hours. Watch PROCEPT BioRobotics Corp. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange PROCEPT BioRobotics Corp. stocks are traded under the ticker PRCT.
We've gathered analysts' opinions on PROCEPT BioRobotics Corp. future price: according to them, PRCT price has a max estimate of 1,288.22 MXN and a min estimate of 652.70 MXN. Watch PRCT chart and read a more detailed PROCEPT BioRobotics Corp. stock forecast: see what analysts think of PROCEPT BioRobotics Corp. and suggest that you do with its stocks.
PRCT reached its all-time high on Oct 29, 2024 with the price of 1,820.06 MXN, and its all-time low was 536.00 MXN and was reached on Jan 20, 2026. View more price dynamics on PRCT chart.
See other stocks reaching their highest and lowest prices.
PRCT stock is 1.39% volatile and has beta coefficient of 1.09. Track PROCEPT BioRobotics Corp. stock price on the chart and check out the list of the most volatile stocks — is PROCEPT BioRobotics Corp. there?
Today PROCEPT BioRobotics Corp. has the market capitalization of ‪26.67 B‬, it has increased by 0.41% over the last week.
Yes, you can track PROCEPT BioRobotics Corp. financials in yearly and quarterly reports right on TradingView.
PROCEPT BioRobotics Corp. is going to release the next earnings report on Feb 24, 2026. Keep track of upcoming events with our Earnings Calendar.
PRCT earnings for the last quarter are −6.97 MXN per share, whereas the estimation was −7.56 MXN resulting in a 7.88% surprise. The estimated earnings for the next quarter are −5.84 MXN per share. See more details about PROCEPT BioRobotics Corp. earnings.
PROCEPT BioRobotics Corp. revenue for the last quarter amounts to ‪1.53 B‬ MXN, despite the estimated figure of ‪1.48 B‬ MXN. In the next quarter, revenue is expected to reach ‪1.69 B‬ MXN.
PRCT net income for the last quarter is ‪−392.50 M‬ MXN, while the quarter before that showed ‪−367.25 M‬ MXN of net income which accounts for −6.88% change. Track more PROCEPT BioRobotics Corp. financial stats to get the full picture.
No, PRCT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 17, 2026, the company has 756 employees. See our rating of the largest employees — is PROCEPT BioRobotics Corp. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PROCEPT BioRobotics Corp. EBITDA is ‪−1.58 B‬ MXN, and current EBITDA margin is −40.70%. See more stats in PROCEPT BioRobotics Corp. financial statements.
Like other stocks, PRCT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PROCEPT BioRobotics Corp. stock right from TradingView charts — choose your broker and connect to your account.